Seicean R, Funariu G, Seicean A, Mocan T, Ciuce C
Clinica Chirurgie I, Universitatea de Medicină şi Farmacie "Iuliu Haţieganu", Cluj-Napoca, România.
Chirurgia (Bucur). 2011 May-Jun;106(3):333-40.
Rectal cancer has a paradoxal prognosis in about 25% of patients, although intraoperative parameters and tumor stage are known as major determinants of prognosis.
This study assessed the prognostic factors in patients with rectal cancer treated without total mesorectal excision in long-term follow-up.
A single center tertiary population included retrospectively 87 patients with rectal cancer operated between 1992 and 2002 using conventional resection. Some 90.5 per cent of the patients had surgery alone and 9.5 per cent had postoperative radiochemotherapy. Patients who did not have adenocarcinoma, those in whom the curative operation was not done, and those who received preoperative radiotherapy were excluded. Median follow-up was 7 years.
Seven-year cancer specific survival was 52% (95% CI:3.21) and only pT, pN and lymphatic invasion were significant as prognostic factors on multivariate analysis. Disease free cancer survival was 56% and only lymphatic invasion was significant for prognosis. The risk of death was higher for abdomino-perineal resection (APR) than for anterior resection (AR), advanced pT stage, vascular and perineural invasion. Local recurrence and distant metastasis were 12.6 and 26.43 per cent respectively for patients. The risk for local reccurence was higher for advanced pT stage, perineural and lymphatic invasion and distal margin invasion. The risk for metastasis was higher for advanced pT stage and vascular invasion.
Advanced tumor stage and lymphatic invasion represent prognostic factors in rectal cancer, suggesting the necessity of adjuvant therapy in cases with lymphatic invasion.
约25%的直肠癌患者预后矛盾,尽管术中参数和肿瘤分期是已知的预后主要决定因素。
本研究评估了长期随访中未行全直肠系膜切除术治疗的直肠癌患者的预后因素。
一项单中心三级人群研究回顾性纳入了1992年至2002年间采用传统切除术的87例直肠癌患者。约90.5%的患者仅接受了手术,9.5%的患者接受了术后放化疗。排除了非腺癌患者、未行根治性手术的患者以及接受术前放疗的患者。中位随访时间为7年。
7年癌症特异性生存率为52%(95%CI:3.21),多因素分析显示只有pT、pN和淋巴侵犯是显著的预后因素。无病癌症生存率为56%,只有淋巴侵犯对预后有显著意义。腹会阴联合切除术(APR)患者的死亡风险高于前切除术(AR)患者,pT分期晚期、血管和神经侵犯患者的死亡风险也更高。患者的局部复发率和远处转移率分别为12.6%和26.43%。pT分期晚期、神经和淋巴侵犯以及远端切缘侵犯患者的局部复发风险更高。pT分期晚期和血管侵犯患者的转移风险更高。
肿瘤分期晚期和淋巴侵犯是直肠癌的预后因素,提示淋巴侵犯患者有必要进行辅助治疗。